These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23168700)

  • 21. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
    Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensively drug-resistant tuberculosis.
    LoBue P
    Curr Opin Infect Dis; 2009 Apr; 22(2):167-73. PubMed ID: 19283912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
    Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
    PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
    OʼDonnell MR; Pillay M; Pillay M; Werner L; Master I; Wolf A; Mathema B; Coovadia YM; Mlisana K; Horsburgh CR; Padayatchi N
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):536-43. PubMed ID: 25886924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XDR tuberculosis and the Indian-subcontinent: effective prevention strategies needed.
    Khan IS; Afzal O; Rai MA
    Tuberculosis (Edinb); 2009 Mar; 89(2):107-8. PubMed ID: 19186104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XDR-TB among suspects under programmatic management of drug-resistant TB in northern India.
    Jain A; Singh PK; Ramakrishna V
    J Glob Antimicrob Resist; 2016 Dec; 7():167-168. PubMed ID: 27837712
    [No Abstract]   [Full Text] [Related]  

  • 29. Extensively drug-resistant tuberculosis.
    Madariaga MG; Lalloo UG; Swindells S
    Am J Med; 2008 Oct; 121(10):835-44. PubMed ID: 18823850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensively drug resistant tuberculosis (XDR-TB) in Chest Disease Institute, 1997-2005.
    Chuchottaworn C
    J Med Assoc Thai; 2010 Jan; 93(1):34-7. PubMed ID: 20196408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Merker M; Nikolaevskaya E; Kohl TA; Molina-Moya B; Pavlovska O; Brännberg P; Dudnyk A; Stokich V; Barilar I; Marynova I; Filipova T; Prat C; Sjöstedt A; Dominguez J; Rzhepishevska O; Niemann S
    Emerg Infect Dis; 2020 Mar; 26(3):481-490. PubMed ID: 32091369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.
    Sharma A; Hill A; Kurbatova E; van der Walt M; Kvasnovsky C; Tupasi TE; Caoili JC; Gler MT; Volchenkov GV; Kazennyy BY; Demikhova OV; Bayona J; Contreras C; Yagui M; Leimane V; Cho SN; Kim HJ; Kliiman K; Akksilp S; Jou R; Ershova J; Dalton T; Cegielski P;
    Lancet Infect Dis; 2017 Jul; 17(7):707-715. PubMed ID: 28499828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and operational value of the extensively drug-resistant tuberculosis definition.
    Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC;
    Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.
    Huang Y; Wu Q; Xu S; Zhong J; Chen S; Xu J; Zhu L; He H; Wang X
    Microb Drug Resist; 2017 Mar; 23(2):236-240. PubMed ID: 27754791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes.
    Tang S; Zhang Q; Yu J; Liu Y; Sha W; Sun H; Fan L; Gu J; Hao X; Yao L; Xiao H
    Scand J Infect Dis; 2011 Apr; 43(4):280-5. PubMed ID: 21247226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review.
    Chisompola NK; Streicher EM; Muchemwa CMK; Warren RM; Sampson SL
    BMC Infect Dis; 2020 May; 20(1):344. PubMed ID: 32404119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for extensively drug-resistant tuberculosis: a review.
    Flor de Lima B; Tavares M
    Clin Respir J; 2014 Jan; 8(1):11-23. PubMed ID: 23875862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.